Salesforce

Salesforce (NYSE:CRM) empowers companies of every size and industry to connect with their customers through the power of data + AI + CRM + trust.

Salesforce Likely to Achieve Accelerated Revenue Growth in FY25, Exceeding Investor Expectations, Morgan Stanley Says

Salesforce (CRM) is expected to achieve accelerated revenue growth through fiscal-year 2025, exceeding investor expectations, Morgan Stanley said in a note e-mailed Thursday. “We see several vectors for Salesforce to drive top-line upside versus muted investor growth expectations, yielding accelerating revenue growth through FY25,” Morgan Stanley said. Investors have modest expectations, but the possibility of increased prices, bundled products, and widespread adoption of data cloud present an appealing balance of risk and reward for Salesforce. Although the surge in GenAI applications might take over a year to materialize, data cloud will likely prove a bridge to better growth in 2024, Morgan Stanley said. Despite a solid and improving positioning for generative AI, the stock continues to trade at a discount to large cap software peers on a growth-adjusted GAAP earnings basis, presenting a “compelling risk-reward ahead,” it added. Morgan Stanley upgraded Salesforce to overweight and increased its price target to […]

Salesforce Likely to Achieve Accelerated Revenue Growth in FY25, Exceeding Investor Expectations, Morgan Stanley Says Read Post »

Salesforce (NYSE:CRM) stock Analyst Ratings

Salesforce (NYSE:CRM) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/21/2023 31.84% Morgan Stanley $290 → $350 Upgrades Equal-Weight → Overweight 12/20/2023 5.47% Wells Fargo → $280 Downgrades Overweight → Equal-Weight 12/18/2023 18.65% Wolfe Research → $315 Upgrades Peer Perform → Outperform 12/01/2023 9.24% Argus Research $275 → $290 Maintains Buy 11/30/2023 9.24% Evercore ISI Group $275 → $290 Maintains Outperform 11/30/2023 13% Raymond James $280 → $300 Maintains Strong Buy 11/30/2023 13% Stifel $275 → $300 Maintains Buy 11/30/2023 3.59% Truist Securities → $275 Reiterates Buy → Buy 11/30/2023 -2.06% JP Morgan $240 → $260 Maintains Overweight 11/30/2023 10.37% JMP Securities $275 → $293 Maintains Market Outperform 11/30/2023 5.47% Mizuho $255 → $280 Maintains Buy 11/30/2023 3.59% Oppenheimer $250 → $275 Maintains Outperform 11/30/2023 4.34% BMO Capital $252 → $277 Maintains Outperform 11/30/2023 9.24% Morgan Stanley $278 → $290 Maintains Equal-Weight

Salesforce (NYSE:CRM) stock Analyst Ratings Read Post »

Salesforce (NYSE:CRM) stock Analyst Ratings

Salesforce (NYSE:CRM) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/20/2023 7.34% Wells Fargo → $280 Downgrades Overweight → Equal-Weight 12/18/2023 20.76% Wolfe Research → $315 Upgrades Peer Perform → Outperform 12/01/2023 11.18% Argus Research $275 → $290 Maintains Buy 11/30/2023 11.18% Evercore ISI Group $275 → $290 Maintains Outperform 11/30/2023 15.01% Raymond James $280 → $300 Maintains Strong Buy 11/30/2023 15.01% Stifel $275 → $300 Maintains Buy 11/30/2023 5.42% Truist Securities → $275 Reiterates Buy → Buy 11/30/2023 -0.33% JP Morgan $240 → $260 Maintains Overweight 11/30/2023 12.33% JMP Securities $275 → $293 Maintains Market Outperform 11/30/2023 7.34% Mizuho $255 → $280 Maintains Buy 11/30/2023 5.42% Oppenheimer $250 → $275 Maintains Outperform 11/30/2023 6.19% BMO Capital $252 → $277 Maintains Outperform 11/30/2023 11.18% Morgan Stanley $278 → $290 Maintains Equal-Weight 11/30/2023 9.26% RBC Capital $240 → $285 Maintains Outperform 11/30/2023 7.34%

Salesforce (NYSE:CRM) stock Analyst Ratings Read Post »

Salesforce (NYSE:CRM) Analyst Ratings

Salesforce (NYSE:CRM) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 18.64% Wolfe Research → $315 Upgrades Peer Perform → Outperform 12/01/2023 9.22% Argus Research $275 → $290 Maintains Buy 11/30/2023 9.22% Evercore ISI Group $275 → $290 Maintains Outperform 11/30/2023 12.99% Raymond James $280 → $300 Maintains Strong Buy 11/30/2023 12.99% Stifel $275 → $300 Maintains Buy 11/30/2023 3.57% Truist Securities → $275 Reiterates Buy → Buy 11/30/2023 -2.08% JP Morgan $240 → $260 Maintains Overweight 11/30/2023 10.35% JMP Securities $275 → $293 Maintains Market Outperform 11/30/2023 5.46% Mizuho $255 → $280 Maintains Buy 11/30/2023 3.57% Oppenheimer $250 → $275 Maintains Outperform 11/30/2023 4.33% BMO Capital $252 → $277 Maintains Outperform 11/30/2023 9.22% Morgan Stanley $278 → $290 Maintains Equal-Weight 11/30/2023 7.34% RBC Capital $240 → $285 Maintains Outperform 11/30/2023 5.46% Wedbush $255 → $280 Maintains Outperform 11/30/2023 5.46% Wells Fargo $265

Salesforce (NYSE:CRM) Analyst Ratings Read Post »

Scroll to Top